A detailed history of Black Rock Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Black Rock Inc. holds 5,384,030 shares of LEGN stock, worth $234 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,384,030
Previous 5,266,188 2.24%
Holding current value
$234 Million
Previous $317 Million 4.69%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$55.06 - $69.99 $6.49 Million - $8.25 Million
117,842 Added 2.24%
5,384,030 $302 Million
Q4 2023

Feb 13, 2024

BUY
$57.25 - $69.74 $36.9 Million - $45 Million
645,154 Added 13.96%
5,266,188 $317 Million
Q3 2023

Nov 13, 2023

SELL
$63.16 - $76.5 $7.74 Million - $9.38 Million
-122,560 Reduced 2.58%
4,621,034 $310 Million
Q2 2023

Aug 11, 2023

BUY
$46.28 - $75.01 $28.5 Million - $46.2 Million
615,641 Added 14.91%
4,743,594 $327 Million
Q1 2023

May 12, 2023

BUY
$43.42 - $57.37 $10.9 Million - $14.4 Million
250,146 Added 6.45%
4,127,953 $199 Million
Q4 2022

Feb 13, 2023

BUY
$38.8 - $55.46 $5.67 Million - $8.1 Million
146,025 Added 3.91%
3,877,807 $194 Million
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $22.3 Million - $33.3 Million
583,851 Added 18.55%
3,731,782 $152 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $55.0 $3.41 Million - $5.59 Million
101,702 Added 3.34%
3,147,931 $173 Million
Q1 2022

May 12, 2022

BUY
$31.02 - $48.18 $19.8 Million - $30.8 Million
639,828 Added 26.59%
3,046,229 $111 Million
Q4 2021

Feb 10, 2022

BUY
$41.14 - $56.98 $64.5 Million - $89.4 Million
1,568,474 Added 187.19%
2,406,401 $112 Million
Q3 2021

Nov 09, 2021

BUY
$35.31 - $50.56 $1.25 Million - $1.79 Million
35,330 Added 4.4%
837,927 $42.4 Million
Q2 2021

Aug 11, 2021

BUY
$25.8 - $41.09 $20.7 Million - $33 Million
802,597 New
802,597 $32.9 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.29B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.